INDIANAPOLIS, Jan. 21, 2016 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company's (NYSE: LLY) Humulin ® R U-500 KwikPen ® (insulin human injection) 500 units ...

The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company's (NYSE: LLY) Humulin ® R U-500 KwikPen ® (insulin human injection) 500 units/mL, a pre-filled device containing Humulin ...

Humulin R U-500 belongs to a group of biologic drugs called insulins. The active ingredient in Humulin R U-500 is recombinant human insulin. The drug comes as a clear liquid that you’ll inject under ...

Do not share your Humulin R U-500 KwikPen®or U-500 syringe with anyone. Even if you have changed the needle, you or the other person can get a serious infection. When using the Humulin R U-500 KwikPen ...

Eli Lilly announced the launch of Humulin R U-500 KwikPen (insulin human injection), a prefilled device containing a highly concentrated formulation of insulin. Eli Lilly announced the launch of ...

The US Food and Drug Administration (FDA) has approved the first prefilled pen device containing concentrated U-500 strength insulin (Humulin R U-500 KwikPen [insulin human injection] 500 units/mL, ...

Humalog (insulin lispro) and Humulin N (insulin isophane human) are brand-name prescription* medications. They’re approved by the Food and Drug Administration (FDA) to help treat type 1 and type 2 ...

Please provide your email address to receive an email when new articles are posted on . The European Medicine Agency’s Committee for Medicinal Products for Human Use recommended approval of Eli Lilly ...

Eli Lilly & Company LLY announced plans to launch lower-priced versions of two of its insulin product, Humalog – Humalog Mix75/25 KwikPen and Humalog Junior KwikPen. The list price of these low-priced ...

Humulin N can cause certain side effects (also called adverse effects), some of which are more common than others. These side effects may be temporary, lasting a few days to weeks. However, if the ...